GT199900087A - Terapia de combinacion para la fragilidad musculoesqueletica. - Google Patents

Terapia de combinacion para la fragilidad musculoesqueletica.

Info

Publication number
GT199900087A
GT199900087A GT199900087A GT199900087A GT199900087A GT 199900087 A GT199900087 A GT 199900087A GT 199900087 A GT199900087 A GT 199900087A GT 199900087 A GT199900087 A GT 199900087A GT 199900087 A GT199900087 A GT 199900087A
Authority
GT
Guatemala
Prior art keywords
combination therapy
musculoskeletal
fragility
musculoskeletal fragility
combination
Prior art date
Application number
GT199900087A
Other languages
English (en)
Spanish (es)
Inventor
Hua Zhu Ke
Mei Li
Lidia Codetta Pan
David Duane Thompson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199900087A publication Critical patent/GT199900087A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GT199900087A 1998-06-16 1999-06-16 Terapia de combinacion para la fragilidad musculoesqueletica. GT199900087A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
GT199900087A true GT199900087A (es) 2000-12-07

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199900087A GT199900087A (es) 1998-06-16 1999-06-16 Terapia de combinacion para la fragilidad musculoesqueletica.

Country Status (30)

Country Link
EP (1) EP1087764A1 (sk)
JP (1) JP2002518326A (sk)
KR (1) KR20010052852A (sk)
CN (1) CN1301160A (sk)
AP (1) AP9901582A0 (sk)
AR (1) AR018869A1 (sk)
AU (1) AU4054799A (sk)
BG (1) BG105041A (sk)
BR (1) BR9911324A (sk)
CA (1) CA2335134A1 (sk)
CO (1) CO5070587A1 (sk)
EA (1) EA200001186A1 (sk)
GT (1) GT199900087A (sk)
HN (1) HN1999000097A (sk)
HR (1) HRP20000859A2 (sk)
HU (1) HUP0102505A3 (sk)
ID (1) ID27599A (sk)
IL (1) IL138630A0 (sk)
IS (1) IS5691A (sk)
MA (1) MA26652A1 (sk)
NO (1) NO20006312L (sk)
OA (1) OA11505A (sk)
PA (1) PA8475901A1 (sk)
PE (1) PE20000646A1 (sk)
PL (1) PL344981A1 (sk)
SK (1) SK18912000A3 (sk)
TN (1) TNSN99124A1 (sk)
TR (1) TR200003544T2 (sk)
WO (1) WO1999065486A1 (sk)
ZA (1) ZA993975B (sk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047735A2 (en) * 1999-02-08 2000-08-17 Mcgill University NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha
ES2274854T3 (es) 2000-05-08 2007-06-01 Pfizer Products Inc. Resolucion enzimatica de moduladores selectivos del receptor de estrogeno.
JP2004507502A (ja) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク 成長ホルモン分泌促進物質のための徐放性製剤
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
JP2010518090A (ja) 2007-02-09 2010-05-27 トランザイム・ファーマ，インコーポレイテッド 大環状グレリン受容体修飾因子およびその使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
ID27599A (id) 2001-04-12
CO5070587A1 (es) 2001-08-28
JP2002518326A (ja) 2002-06-25
NO20006312D0 (no) 2000-12-12
OA11505A (en) 2004-05-07
ZA993975B (en) 2000-12-15
PL344981A1 (en) 2001-11-19
HUP0102505A3 (en) 2002-12-28
HRP20000859A2 (en) 2001-04-30
TNSN99124A1 (fr) 2005-11-10
TR200003544T2 (tr) 2001-04-20
KR20010052852A (ko) 2001-06-25
NO20006312L (no) 2000-12-12
PE20000646A1 (es) 2000-08-05
CN1301160A (zh) 2001-06-27
HUP0102505A2 (hu) 2001-11-28
IL138630A0 (en) 2001-10-31
CA2335134A1 (en) 1999-12-23
AR018869A1 (es) 2001-12-12
EP1087764A1 (en) 2001-04-04
BG105041A (en) 2001-08-31
MA26652A1 (fr) 2004-12-20
SK18912000A3 (sk) 2001-10-08
AP9901582A0 (en) 1999-06-30
EA200001186A1 (ru) 2001-06-25
PA8475901A1 (es) 2000-05-24
WO1999065486A1 (en) 1999-12-23
IS5691A (is) 2000-10-27
AU4054799A (en) 2000-01-05
BR9911324A (pt) 2001-04-03
HN1999000097A (es) 1999-11-03

Similar Documents

Publication Publication Date Title
PA8521701A1 (es) Derivados de pirazol
GT199800158A (es) Agonistas de prostaglandinas.
HUP9900962A2 (hu) Fertőtlenítőkészítmények és eljárások felületek fertőtlenítésére
MX9205432A (es) Compuestos inhibidores de la biosintesis de leucotrienos y composicion farmaceutica que los contiene.
ES2148345T3 (es) Composicion farmaceutica con ciclosporina a, un derivado de vitamina e y un emulsionante.
AR020021A1 (es) Composicion para el tratamiento de cancer usando aceites esenciales de plantas naturales con moduladores de transduccion de senal
PA8435201A1 (es) Derivados 6,6- o 6,7-biciclicos sustituidos que contienen pirido o pirimido.
BR9804437A (pt) Compostos para a osteoporose
PA8452701A1 (es) Agonistas de prostaglandinas
CR9465A (es) Compuestos mejorados farmacocineticamente
ES2193337T3 (es) Utilizacion de sales de estroncio para el tratamiento de la artrosis.
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
BR9909819A (pt) Amida, uso de amidas, e, preparação farmacêutica para uso oral, parenteral ou intraperitoneal
BR9815469A (pt) Inibidores de protease
TR199902703T2 (xx) Proteaz inhibit�rleri.
BR9807655A (pt) Uso de inibidores de lipase gastrintestinal.
GT199900087A (es) Terapia de combinacion para la fragilidad musculoesqueletica.
PT1105114E (pt) Composicoes farmaceuticas topicas contendo nimesulide
ES2067874T3 (es) Derivados de acetamida.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
SE9801494D0 (sv) Novel use
DK0658585T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og midler indeholdende disse som antik
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
NO981019D0 (no) Deodoriserende preparater inneholdende kationiske biopolymerer, aluminiumklorhydrat og esteraseinhibitorer
PT952975E (pt) Compostos bi-aromaticos ligados por um radical hetero-etinileno e composicoes farmaceuticas e cosmeticas que os contem